[D-dimer dosage for the prediction of recurrent venous thromboembolism].
The optimal duration of oral anticoagulation therapy for venous thromboembolism is controversial. Recent studies focused on identifying risk factors associated with recurrent thromboembolism in order to identify patients at particularly high risk for recurrence and optimize the duration of anticoagulant treatment. Recent studies show that an elevated D-dimer level one month after stopping the initial course of anticoagulants is associated with higher risk of recurrence. Despite theses results, evidence of using D-dimer for tailoring duration of anticoagulation is still sparse.
Guanella
R
R
Service de Médecine Interne Générale, Département de Médecine, HUG, Genève.
Righini
M
M
Perrier
A
A
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D005338:Fibrin Fibrinogen Degradation Products / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000188:drug therapy*
D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D